Market Place
Sourcing Support
All News #Library
Quality
Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply
14 Jun 2019 //
FIERCE PHARMA
Sartan recall, China high-tech board and more
08 Mar 2019 //
FIERCE PHARMA
Blood pressure drug recall: FDA investigates foreign manufacturers
14 Jan 2019 //
USA TODAY
A wave of drug recalls hits Indian pharma firms in US
09 Jan 2019 //
DNA INDIA
FDA updates on ARB recalls including valsartan, losartan and irbesartan
21 Dec 2018 //
FDA
Valsartan products under recall - Updated October 24, 2018
26 Oct 2018 //
FDA
FDA posts laboratory analysis of NDMA levels in recalled valsartan products
09 Oct 2018 //
FDA
EU, US Ban Manufacturer use of Valsartan From China’s Zhejiang Huahai
29 Sep 2018 //
RAPS
EMA Extends Valsartan Review to Include Four More Active Substances
22 Sep 2018 //
RAPS
Valsartan Recalls: Health Canada Spots Second Impurity
13 Sep 2018 //
RAPS
FDA updates on valsartan recalls
09 Aug 2018 //
FDA
Valsartan recall: 4 things patients should know
20 Jul 2018 //
CNN
FDA Warns Indian Contract Manufacturer Hetero Labs
29 Aug 2017 //
RAPS
28 Unique Data Integrity Deficiencies That Aren’t Really Unique
02 Jun 2017 //
FDAZILLA
Hetero Labs plant hit with Form 483 for suspicious shredding of documents
26 Jan 2017 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.